Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone in Chagas Cardiomyopathy
NCT03193749Phase 3Unknown
- Sponsor
- Fundación Cardioinfantil Instituto de Cardiología
- Start
- Jun 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chagas cardiomyopathy (CCC) comparing Amiodarone Hydrochloride with Placebo (2 arms). Primary endpoint: Positive PCR for Trypanosoma cruzi at 6 months. Status: unknown.
02
Drugs
amiodarone
03
Conditions
Chagas cardiomyopathy (CCC)
Beyond the preview
Go deeper on NCT03193749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03193749.